Could cannabis ease fibromyalgia pain? new trial investigates

NCT ID NCT07498023

Ongoing Symptom relief Sponsor: Federal University of Latin American Integration Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a full-spectrum cannabis extract containing CBD and THC in 36 women with fibromyalgia, a condition causing widespread pain, fatigue, and sleep problems. Participants will receive different doses over six months to see if it improves symptoms and quality of life. It is an early-stage, open-label trial, meaning everyone knows they are getting the treatment, so results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: cannabis extract (CBD and THC)
What this could lead to: If successful, this could point toward a new treatment option for fibromyalgia that reduces pain and improves quality of life with fewer side effects than current medications.
What could go wrong: This is a very small, early-phase pilot study with only 36 participants and no placebo group, so results may not be reliable or generalizable. The optimal dose and long-term safety are still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia fibromyalgia Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FIBROMYALGIA

Contacts and locations

Locations

Universidade Federal da Integração Latino-Americana

Foz do Iguaçu, Paraná, 85870-650, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.